Randomised Study to Compare the Effect of r-Hu-EPO Administration With Transfusion of Red Blood Cell Concentrates and Also With the Administration of Polyvitamins in Anemic and Tired Patients Presenting a Bad Prognostic in Middle Course
Phase 3
Terminated
- Conditions
- - Medico-Economic Aspects (Evaluation of Medical Costs Related to the Three Strategies and Evaluation of Cost/Efficacy)
- Registration Number
- NCT00180999
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Brief Summary
Randomised study to compare the effect of r-Hu-EPO administration with transfusion of Red Blood cell concentrates and also with the administration of polyvitamins in anemic and tired patients presenting a bad prognostic in middle course.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 420
Inclusion Criteria
- Both sexes
- 18-70 yrs
- metastatic or locally advanced cancer
- Life expectancy > 3 months
- hemoglobin between 7 and 10 g/100ml
- no contraindication to r-Hu-EPO
- with written informed consent at entry time
Read More
Exclusion Criteria
Not provided
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Quality of life, in particular when related to tiredness (FACT F)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Institut Gustave-Roussy
🇫🇷Villejuif, France